Patent families for mAbs from 4 biotech companies

Comparing #mAb and #Chemical #Innovation, expertise in mAbs is concentrated in a few, primarily #HighIncomeNations, according to Motta-Santos et al. This contrasts with broader distribution in the #ChemicalDrug sector. bit.ly/3Zxi1dG #MonoclonalAntibody #PatentAnalysis #Chemistry #BiotechPatents